|
CA136551A
(en)
|
1911-08-03 |
1911-10-31 |
Hedwig Heeron |
Rolling mill
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
IE20030749A1
(en)
|
1991-05-03 |
2003-11-12 |
Indiana University Foundation |
Human notch and delta binding domains in torporythmic proteins, and methods based thereon
|
|
US5420032A
(en)
|
1991-12-23 |
1995-05-30 |
Universitge Laval |
Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
|
|
US5792632A
(en)
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
|
US5780300A
(en)
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
|
EP1616958A3
(en)
*
|
1996-11-07 |
2006-02-08 |
Lorantis Limited |
Notch-ligands for use in immunotherapy
|
|
WO2000014257A1
(en)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Fusion receptors specific for prostate-specific membrane antigen and uses thereof
|
|
CA2410510A1
(en)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Artificial antigen presenting cells and methods of use thereof
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US6689744B2
(en)
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
US20030119771A1
(en)
|
2001-08-22 |
2003-06-26 |
Rompaey Luc Van |
Modulators of bone homeostasis identified in a high-throughput screen
|
|
JP2003093048A
(ja)
*
|
2001-09-26 |
2003-04-02 |
Asahi Kasei Corp |
新規細胞製剤製造用培養媒体
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US8206965B2
(en)
|
2002-03-15 |
2012-06-26 |
Cellectis S.A. |
Hybrid and single chain meganucleases and use thereof
|
|
EP1492816A2
(en)
*
|
2002-04-05 |
2005-01-05 |
Lorantis Limited |
Modulators of the notch signalling pathway and uses thereof in medical treatment
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
JP2006513153A
(ja)
*
|
2002-10-09 |
2006-04-20 |
ロランティス リミテッド |
免疫機能の調節
|
|
WO2004064863A1
(en)
*
|
2003-01-23 |
2004-08-05 |
Lorantis Limited |
Treatment of autoimmune diseases using an activator for the notch signaling pathway
|
|
US20060206949A1
(en)
|
2003-01-28 |
2006-09-14 |
Sylvain Arnould |
Custom-made meganuclease and use thereof
|
|
CA2589279A1
(en)
*
|
2004-11-24 |
2006-06-01 |
Val-Chum, S.E.C. |
Methods to identify, prepare, and use naive t cell recent thymic emigrants
|
|
WO2007027226A2
(en)
*
|
2005-04-28 |
2007-03-08 |
Board Of Regents, The University Of Texas System |
Systems and methods for the production of differentiated cells
|
|
DK3246403T3
(da)
|
2005-10-18 |
2020-10-26 |
Prec Biosciences |
Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
|
|
EP2081962B1
(en)
|
2006-10-19 |
2018-10-03 |
Genentech, Inc. |
Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
|
|
JP5478254B2
(ja)
|
2006-10-19 |
2014-04-23 |
ジェネンテック, インコーポレイテッド |
抗ノッチ3アゴニスト抗体とノッチ3関連疾患の治療におけるその使用
|
|
WO2008092445A2
(de)
*
|
2007-01-30 |
2008-08-07 |
Deutsches Rheuma-Forschungszentrum Berlin |
Verfahren zur modulation der immunantwort durch aktivierung oder inaktivierung des notch und/oder stat4 signalweges
|
|
US8389282B2
(en)
|
2007-03-30 |
2013-03-05 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
US9221902B2
(en)
|
2008-11-07 |
2015-12-29 |
Fabrus, Inc. |
Combinatorial antibody libraries and uses thereof
|
|
WO2010059543A1
(en)
|
2008-11-20 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
|
|
WO2010141249A2
(en)
|
2009-06-02 |
2010-12-09 |
Merck Sharp & Dohme Corp. |
Generation, characterization and uses thereof of anti-notch3 antibodies
|
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
US10316289B2
(en)
*
|
2012-09-06 |
2019-06-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing T memory stem cell populations
|
|
EP3064585B1
(en)
|
2012-12-12 |
2020-02-05 |
The Broad Institute, Inc. |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
US10696946B2
(en)
*
|
2013-02-22 |
2020-06-30 |
The Board Of Trustees Of The University Of Illinois |
T-REG cell expansion
|
|
US9683039B2
(en)
|
2013-03-14 |
2017-06-20 |
New York University |
Notch agonists for the treatment of cancer
|
|
EP3760719A1
(en)
|
2013-11-18 |
2021-01-06 |
CRISPR Therapeutics AG |
Crispr-cas system materials and methods
|
|
WO2015179633A1
(en)
|
2014-05-22 |
2015-11-26 |
Fred Hutchinson Cancer Research Center |
Lilrb2 and notch-mediated expansion of hematopoietic precursor cells
|
|
KR102382905B1
(ko)
|
2014-06-04 |
2022-04-04 |
프레드 헛친슨 켄서 리서치 센터 |
노치 1 및/또는 노치 2 작용제를 사용한 줄기 세포의 확장 및 생착
|
|
RU2716716C2
(ru)
*
|
2014-10-27 |
2020-03-16 |
Фред Хатчинсон Кэнсер Рисёрч Сентер |
Композиции и способы для бустинга эффективности адоптивной клеточной иммунотерапии
|
|
WO2017070333A1
(en)
*
|
2015-10-20 |
2017-04-27 |
Cellular Dynamics International, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
|
KR102908806B1
(ko)
*
|
2015-10-22 |
2026-01-07 |
주노 테라퓨틱스 게엠베하 |
세포의 배양 방법 및 이를 위한 키트와 장치
|
|
KR102929174B1
(ko)
*
|
2015-10-30 |
2026-02-20 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
줄기세포로부터 t-세포를 생산하는 방법 및 상기 t-세포를 이용한 면역치료 방법
|
|
US12076342B2
(en)
*
|
2016-04-08 |
2024-09-03 |
The Governing Council Of The University Of Toronto |
Method for generating progenitor t cells from stem and/or progenitor cells and use of same
|
|
WO2018017827A1
(en)
|
2016-07-22 |
2018-01-25 |
Fred Hutchinson Cancer Research Center |
Bi-specific molecule for cell-specific notch inhibition and related methods and compositions
|